{"slug":"ss-31-brain-fog","verification":{"valid":true,"entries":2,"head":"bb59b259ec00e13b0024ef9b43ad72e3dd279485a7fdb3c24540abe9d05fdef3"},"energy":{"passes":2,"tokens_in":13976,"tokens_out":2411,"tokens_total":16387,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"bb59b259ec00e13b0024ef9b43ad72e3dd279485a7fdb3c24540abe9d05fdef3"},"provenance":[{"ts":"2026-06-29T23:58:54.013Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Brain Fog\nSlug: ss-31-brain-fog\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Statin-associated cognitive effects\",\"condition_key\":\"statin-brain-fog\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Statin-associated cognitive effects\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **Statin-associated cognitive effects** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Statin-associated cognitive effects** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"","response":"{\n  \"slug\": \"ss-31-brain-fog\",\n  \"title\": \"SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Statin-associated cognitive effects\\n\\nStatin use carries a rare FDA-noted association with reversible cognitive symptoms such as memory loss or confusion in post-marketing reports. The mechanism is not fully established but may involve reduced cholesterol synthesis in the brain or effects on mitochondrial function in neurons. No large human trials link statins directly to permanent brain damage; symptoms are typically described as non-serious and resolve after discontinuation.\\n\\nIf mitochondrial oxidative stress or impaired energy production in brain cells contributes to your symptoms, that points to a repair pathway rather than simple symptom suppression.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about Statin-associated cognitive effects — what breaks down matters before any compound name.\\n2. Therefore for you: If mitochondrial dysfunction in brain cells is part of your problem, SS-31 is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms.\\n3. SS-31 binds cardiolipin, which can stabilize electron transport chain function and reduce reactive oxygen species leakage in preclinical models.\\n4. If your cognitive effects trace to oxidative stress or synaptic loss in the hippocampus, this stabilization step precedes observed improvements in memory tasks in animal inflammation models.\\n\\n## How these fit together\\n\\nSingle-compound focus — SS-31 targets the mitochondrial layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile, but none are in scope here.\\n\\n## What the evidence actually shows\\n\\nPreclinical (mechanistic tier): In a 2019 mouse study, lipopolysaccharide (LPS) injection produced mitochondrial dysfunction, oxidative stress, synaptic loss, ","tokens_in":13976,"tokens_out":2411,"cost":0,"prev":"genesis","hash":"56f89b04e54ddfddc5d87b142ef8d051951fb5613de8a906121565907d228c4c"},{"ts":"2026-07-17T02:42:01.395Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-brain-fog","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"56f89b04e54ddfddc5d87b142ef8d051951fb5613de8a906121565907d228c4c","hash":"bb59b259ec00e13b0024ef9b43ad72e3dd279485a7fdb3c24540abe9d05fdef3"}]}